Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Viral Infections with Risk of Human Lymphomas, Egypt.

Asian Pacific journal of cancer prevention : APJCP·2016
Same author

Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patients.

Journal of the Egyptian National Cancer Institute·2013
Same author

FHIT, EGFR, and MSH2: possible etiopathologic, prognostic, and predictive role in non-small cell lung carcinoma in Egyptian patients.

Applied immunohistochemistry & molecular morphology : AIMM·2013
Same author

Clinicopathologic significance of molecular classification of breast cancer: relation to nottingham prognosis index.

Journal of the Egyptian National Cancer Institute·2011
Same author

Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validity.

Journal of the Egyptian National Cancer Institute·2009
Same author

Evaluation of MIB-1 and p53 overexpression as risk factors in large cell non-Hodgkin lymphoma in adults.

Journal of the Egyptian National Cancer Institute·2009

Related Experiment Video

Updated: Jun 25, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Review article composite lymphoma.

Nadia M Mokhtar1

  • 1The Department of Pathology, National Cancer Institute, Cairo University.

Journal of the Egyptian National Cancer Institute
|February 5, 2009
PubMed
Summary

Composite lymphoma (CL) is a rare condition involving two or more distinct lymphoma types in one site. Accurate diagnosis is crucial due to varied prognoses and treatments for this complex lymphoma.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Composite lymphoma (CL) is defined as two or more distinct lymphoma types occurring at a single anatomic site, either concurrently or sequentially.
  • Unlike lymphoma transformation, CL requires proof of two distinct clones via morphological and laboratory tests.
  • The pathogenesis of CL is complex and multifactorial, with theories including clonal selection, genomic instability, common precursor cells, and viral factors like Epstein-Barr virus (EBV).

Purpose of the Study:

  • To review the definition, pathogenesis, diagnosis, and clinical significance of composite lymphoma.
  • To highlight the increasing identification of CL due to advancements in molecular diagnostics.
  • To emphasize the importance of accurate diagnosis for appropriate patient management and understanding clonal evolution.

Related Experiment Videos

Last Updated: Jun 25, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Main Methods:

  • Morphological assessment confirmed by various laboratory tests including immunohistochemistry, flow cytometry, PCR, cytogenetics, FISH, in-situ hybridization, DNA sequencing, and cDNA microarray.
  • Laser capture microdissection enhances diagnostic accuracy.
  • Review of reported combinations of CL, such as multiple B-cell lymphomas, B-cell and T-cell lymphomas, and Hodgkin lymphoma (HL) with non-Hodgkin lymphoma (NHL).

Main Results:

  • Composite lymphoma is increasingly identified, necessitating careful diagnostic evaluation.
  • Multiple combinations of lymphoma types can occur within a single anatomic site.
  • Accurate diagnosis is critical as different lymphoma subtypes within CL have distinct natural histories, prognoses, and treatment requirements.

Conclusions:

  • Advancements in molecular diagnostics are leading to more frequent identification of composite lymphoma.
  • Accurate diagnosis of CL is essential for tailoring treatment and predicting patient outcomes.
  • Studying CL cases provides insights into the pathogenic mechanisms and clonal evolution in lymphoma development.